70 Diabetic Retinopathy

measures. Our data are unique both in terms of the length of time over which patients are followed and in the range of health outcome monitored. (3) We will assess the impact of diabetes, glaucoma, and macular degeneration on total Medicare and Medicaid program cost and on costs privately incurred. Program cost will include cost of vision and non-vision services. In our framework, program cost and patient adherence to guidelines will be jointly determined. (4) We will replicate the analysis of the first 2 objectives for complications of diabetes other than for eyes. We will also specify and estimate a dynamic model of utilization of Medicare-covered services by persons with diabetes -- both vision and nonvision care. The main database will be the National Long-Term Care Survey (NLTCS) for 1982-2001, merged with Medicare claims data for 1982-2001. Eleven papers are planned.

Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen

E-Journals: PubMed Central3

PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “diabetic retinopathy” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for diabetic retinopathy in the PubMed Central database:

•Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. by Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP.; 1999 Sep 14; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=17969

•Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. by Maberley D, Walker H, Koushik A, Cruess A.; 2003 Jan 21; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=140424

The National Library of Medicine: PubMed

One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater

3Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.

4With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age.

5The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.

6PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.

Studies 71

number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals.

To generate your own bibliography of studies dealing with diabetic retinopathy, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “diabetic retinopathy” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for diabetic retinopathy (hyperlinks lead to article summaries):

•A Bayesian analysis of the 4-year follow-up data of the Wisconsin epidemiologic study of diabetic retinopathy.

Author(s): Angers JF, Biswas A.

Source: Statistics in Medicine. 2004 February 28; 23(4): 601-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14755392

•A case of progression of diabetic retinopathy during pregnancy.

Author(s): Agardh E.

Source: Acta Ophthalmologica Scandinavica. 2002 October; 80(5): 524-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12390165

•A comparative study of panretinal photocoagulation and vitrectomy for advanced diabetic retinopathy.

Author(s): Brown CD.

Source: Military Medicine. 2003 July; 168(7): 553-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12901466

•A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

Author(s): Beck RW, Moke PS, Turpin AH, Ferris FL 3rd, SanGiovanni JP, Johnson CA, Birch EE, Chandler DL, Cox TA, Blair RC, Kraker RT.

Source: American Journal of Ophthalmology. 2003 February; 135(2): 194-205. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12566024

•A contribution of image processing to the diagnosis of diabetic retinopathy--detection of exudates in color fundus images of the human retina.

Author(s): Walter T, Klein JC, Massin P, Erginay A.

Source: Ieee Transactions on Medical Imaging. 2002 October; 21(10): 1236-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12585705

72 Diabetic Retinopathy

•A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Author(s): Peterlin B, Globocnik Petrovic M, Makuc J, Hawlina M, Petrovic D. Source: Journal of Human Genetics. 2003; 48(12): 646-9. Epub 2003 November 15.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14618419

•A new view of diabetic retinopathy: a neurodegenerative disease of the eye.

Author(s): Barber AJ.

Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2003 April; 27(2): 283-90. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12657367

•A simplified diabetic retinopathy scale.

Author(s): Chew EY.

Source: Ophthalmology. 2003 September; 110(9): 1675-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=13129860

•Aggravation of proliferative diabetic retinopathy after laser in situ keratomileusis.

Author(s): Ghanbari H, Ahmadieh H.

Source: Journal of Cataract and Refractive Surgery. 2003 November; 29(11): 2232-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14670438

•Alterations of fatty acid composition of erythrocyte membrane in type 2 diabetes patients with diabetic retinopathy.

Author(s): Kulacoglu DN, Kocer I, Kurtul N, Keles S, Baykal O.

Source: Japanese Journal of Ophthalmology. 2003 November-December; 47(6): 551-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14636844

•Ambulatory photographic screening for diabetic retinopathy in nursing homes.

Author(s): Anderson S, Broadbent DM, Swain JY, Vora JP, Harding SP. Source: Eye (London, England). 2003 August; 17(6): 711-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12928682

•Aqueous flare and macular edema in eyes with diabetic retinopathy.

Author(s): Jandrasits K, Krepler K, Wedrich A.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2003 January-February; 217(1): 4952. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12566873

Studies 73

•Aspirin for diabetic retinopathy.

Author(s): Kohner EM.

Source: Bmj (Clinical Research Ed.). 2003 November 8; 327(7423): 1060-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14604902

•Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan.

Author(s): Liu WJ, Lee LT, Yen MF, Tung TH, Williams R, Duffy SW, Chen TH.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 September; 20(9): 727-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12925052

•Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes.

Author(s): Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P. Source: Diabetes. 2004 March; 53(3): 861-4.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14988276

•Automated detection of diabetic retinopathy in a fundus photographic screening population.

Author(s): Larsen N, Godt J, Grunkin M, Lund-Andersen H, Larsen M.

Source: Investigative Ophthalmology & Visual Science. 2003 February; 44(2): 767-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12556412

•Automated detection of diabetic retinopathy in digital retinal images: a tool for diabetic retinopathy screening.

Author(s): Usher D, Dumskyj M, Himaga M, Williamson TH, Nussey S, Boyce J. Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2004 January; 21(1): 84-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14706060

•Automated detection of fundus photographic red lesions in diabetic retinopathy.

Author(s): Larsen M, Godt J, Larsen N, Lund-Andersen H, Sjolie AK, Agardh E, Kalm H, Grunkin M, Owens DR.

Source: Investigative Ophthalmology & Visual Science. 2003 February; 44(2): 761-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12556411

•Awareness of diabetic retinopathy among diabetics.

Author(s): Verma L, Elankumaran P, Prakash G, Venkatesh P, Tewari HK. Source: Indian J Ophthalmol. 2002 December; 50(4): 355. No Abstract Available.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12532507

74 Diabetic Retinopathy

•Awareness of diabetic retinopathy among diabetics.

Author(s): Roy P.

Source: Indian J Ophthalmol. 2003 December; 51(4): 365; Author Reply 365. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14750634

•Background diabetic retinopathy in Harare, Zimbabwe.

Author(s): Bartels MC, Macheka BM, Guramantunhu S, Scheenloop JJ, Stilma JS. Source: Trop Doct. 1999 July; 29(3): 189-90. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10448253

•Barriers to compliance with screening guidelines for diabetic retinopathy.

Author(s): Mukamel DB, Bresnick GH, Wang Q, Dickey CF. Source: Ophthalmic Epidemiology. 1999 March; 6(1): 61-72.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10384685

•Barriers to prevention of vision loss caused by diabetic retinopathy.

Author(s): Klein R.

Source: Archives of Ophthalmology. 1997 August; 115(8): 1073-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9258233

•Basement membrane abnormalities in human eyes with diabetic retinopathy.

Author(s): Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, Sado Y, Huang ZS, Nesburn AB, Kenney MC.

Source: The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 1996 December; 44(12): 1469-79. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8985139

•Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy.

Author(s): Koznarova R, Saudek F, Sosna T, Adamec M, Jedinakova T, Boucek P, Bartos V, Lanska V.

Source: Cell Transplantation. 2000 November-December; 9(6): 903-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11202576

•Benefits of training junior physicians to detect diabetic retinopathy--the Glasgow experience.

Author(s): Bibby K, Barrie T, Patterson KR, MacCuish AC.

Source: Journal of the Royal Society of Medicine. 1992 June; 85(6): 326-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1625263

Studies 75

•Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.

Author(s): Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Source: Nature Medicine. 2003 March; 9(3): 294-9. Epub 2003 February 18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12592403

•Beyond retinal screening: digital imaging in the assessment and follow-up of patients with diabetic retinopathy.

Author(s): Kerr D, Cavan DA, Jennings B, Dunnington C, Gold D, Crick M.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 1998 October; 15(10): 878-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9796890

•BglII gene polymorphism of the alpha2beta1 integrin gene is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes.

Author(s): Petrovic MG, Hawlina M, Peterlin B, Petrovic D.

Source: Journal of Human Genetics. 2003; 48(9): 457-60. Epub 2003 August 23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12938014

•Binocular indirect panretinal laser photocoagulation for the treatment of proliferative diabetic retinopathy.

Author(s): Gurelik G, Coney JM, Zakov ZN.

Source: Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye. 2004 March-April; 35(2): 94-102. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15088818

•Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy.

Author(s): Sebag J, Buckingham B, Charles MA, Reiser K.

Source: Archives of Ophthalmology. 1992 October; 110(10): 1472-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1417549

•Blocking angiogenesis in diabetic retinopathy.

Author(s): Bonn D.

Source: Lancet. 1996 August 31; 348(9027): 604. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8815360

•Blood glucose and diabetic retinopathy.

Author(s): Orosz L, Udvardy M, Feher A, Vincze P, Madacsy L. Source: Bmj (Clinical Research Ed.). 1992 May 9; 304(6836): 1244-5.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1515807

76 Diabetic Retinopathy

•Blood glucose concentrations and progression of diabetic retinopathy.

Author(s): Wolff SP.

Source: Bmj (Clinical Research Ed.). 1992 February 22; 304(6825): 505-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1547434

•Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.

Author(s): Brinchmann-Hansen O, Dahl-Jorgensen K, Sandvik L, Hanssen KF. Source: Bmj (Clinical Research Ed.). 1992 January 4; 304(6818): 19-22.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1734985

•Blood pressure control and diabetic retinopathy.

Author(s): Klein R, Klein BE.

Source: The British Journal of Ophthalmology. 2002 April; 86(4): 365-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11914198

•Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.

Author(s): Engler C, Krogsaa B, Lund-Andersen H.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1991; 229(5): 442-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1937077

•Bovine factor VIII derivative in the treatment of non-proliferative diabetic retinopathy.

Author(s): Bandello F, Lattanzio R, Maestranzi G, Brancato R.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 1995; 209(3): 149-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7630622

•Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations.

Author(s): Archer DB.

Source: Eye (London, England). 1999 August; 13 ( Pt 4): 497-523. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10692923

•Breakdown of the blood-aqueous barrier after argon laser panretinal photocoagulation for proliferative diabetic retinopathy.

Author(s): Moriarty AP, Spalton DJ, Shilling JS, Ffytche TJ, Bulsara M. Source: Ophthalmology. 1996 May; 103(5): 833-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8637696

Studies 77

•Can a cilio-retinal artery influence diabetic retinopathy?

Author(s): Tong L.

Source: The British Journal of Ophthalmology. 2003 July; 87(7): 929. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12812912

•Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.

Author(s): Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2002 September; 240(9): 735-8. Epub 2002 August 21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12271370

•CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis.

Author(s): Canton A, Martinez-Caceres EM, Hernandez C, Espejo C, Garcia-Arumi J, Simo R.

Source: Archives of Ophthalmology. 2004 May; 122(5): 743-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15136323

•Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.

Author(s): Nishimura M, Ikeda T, Ushiyama M, Kinoshita S, Yoshimura M. Source: Clinical Science (London, England : 1979). 2000 January; 98(1): 9-14.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10600653

•Changes of nailfold microcirculation in patients of type II diabetes mellitus with diabetic retinopathy.

Author(s): Yi Y, Baoyu W, Shenyuan Y, Liangxiang Z, Hanqing F, Yuantao L.

Source: Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'o Hsueh Tsa Chih / Chinese Academy of Medical Sciences. 1999 December; 14(4): 233-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12894899

•Circulating antipericyte autoantibodies in diabetic retinopathy.

Author(s): Attawia MA, Nayak RC.

Source: Retina (Philadelphia, Pa.). 1999; 19(5): 390-400. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10546933

•Clinical outcomes following laser photocoagulation treatment for diabetic retinopathy at a large Australian ophthalmic hospital.

Author(s): Yi Q, Bamroongsuk P, McCarty DJ, Mukesh BN, Harper CA. Source: Clinical & Experimental Ophthalmology. 2003 August; 31(4): 305-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12880454

78 Diabetic Retinopathy

•Combining phacoemulsification and vitrectomy in patients with proliferative diabetic retinopathy.

Author(s): Lahey JM, Francis RR, Kearney JJ, Cheung M.

Source: Current Opinion in Ophthalmology. 2004 June; 15(3): 192-6. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15118505

•Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases.

Author(s): Lahey JM, Francis RR, Kearney JJ. Source: Ophthalmology. 2003 July; 110(7): 1335-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12867387

•Comparison of optometry vs digital photography screening for diabetic retinopathy in a single district.

Author(s): Tu KL, Palimar P, Sen S, Mathew P, Khaleeli A. Source: Eye (London, England). 2004 January; 18(1): 3-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14707956

•Comparison of the amblyopia treatment study HOTV and electronic-early treatment of diabetic retinopathy study visual acuity protocols in children aged 5 to 12 years.

Author(s): Rice ML, Leske DA, Holmes JM.

Source: American Journal of Ophthalmology. 2004 February; 137(2): 278-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14962417

•Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy.

Author(s): Scanlon PH, Malhotra R, Greenwood RH, Aldington SJ, Foy C, Flatman M, Downes S.

Source: The British Journal of Ophthalmology. 2003 October; 87(10): 1258-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14507762

•Comparison of two, three and four 45 degrees image fields obtained with the Topcon CRW6 nonmydriatic camera for screening for diabetic retinopathy.

Author(s): Perrier M, Boucher MC, Angioi K, Gresset JA, Olivier S. Source: Can J Ophthalmol. 2003 December; 38(7): 569-74.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14740798

•Comparison of venous filling times and SLO findings at each quadrant region in diabetic retinopathy.

Author(s): Kang HR, Yang YS.

Source: Korean J Ophthalmol. 2003 December; 17(2): 133-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14717492

Studies 79

•Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients.

Author(s): Trevisan R, Vedovato M, Mazzon C, Coracina A, Iori E, Tiengo A, Del Prato S.

Source: Diabetes Care. 2002 November; 25(11): 2026-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12401751

•Correlation between erythrocyte aldose reductase level and human diabetic retinopathy.

Author(s): Oishi N, Kubo E, Takamura Y, Maekawa K, Tanimoto T, Akagi Y. Source: The British Journal of Ophthalmology. 2002 December; 86(12): 1363-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12446366

•Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy.

Author(s): Polak BC, Crijns H, Casparie AF, Niessen LW.

Source: Health Policy (Amsterdam, Netherlands). 2003 April; 64(1): 89-97. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12644331

•Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales.

Author(s): Wilson A, Baker R, Thompson J, Grimshaw G.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2004 March; 21(3): 271-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15008839

•Current status of screening for diabetic retinopathy in the UK.

Author(s): Warburton T.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 August; 20(8): 690. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12873303

•Current status of screening for diabetic retinopathy in the UK.

Author(s): Morris A, Slattery J, Olson J, Leese G, Harvey R.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 July; 20(7): 603-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12823247

80 Diabetic Retinopathy

•Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.

Author(s): Simo R, Lecube A, Sararols L, Garcia-Arumi J, Segura RM, Casamitjana R, Hernandez C.

Source: Diabetes Care. 2002 December; 25(12): 2282-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12453974

•Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis.

Author(s): Reiner AP, Agardh E, Teramura G, Gaur P, Gaur LK, Agardh CD. Source: Thrombosis and Haemostasis. 2003 January; 89(1): 142-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12540964

•Diabetic papillopathy as a risk factor for progression of diabetic retinopathy.

Author(s): Bandello F, Menchini F.

Source: Retina (Philadelphia, Pa.). 2004 February; 24(1): 183-4; Author Reply 184. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15076973

•Diabetic papillopathy as a risk factor for progression of diabetic retinopathy: reply.

Author(s): Lee SY, Ang CL.

Source: Retina (Philadelphia, Pa.). 2004 February; 24(1): 184-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15076975

•Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

Author(s): Ciulla TA, Amador AG, Zinman B.

Source: Diabetes Care. 2003 September; 26(9): 2653-64. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12941734

•Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

Author(s): Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL.

Source: Investigative Ophthalmology & Visual Science. 2004 March; 45(3): 910-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14985310

•Diabetic retinopathy in African Americans: vision impairment, prevalence, incidence, and risk factors.

Author(s): Baker RS.

Source: International Ophthalmology Clinics. 2003 Fall; 43(4): 105-22. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14574205

Studies 81

•Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes.

Author(s): Santos KG, Tschiedel B, Schneider J, Souto K, Roisenberg I. Source: Diabetes Research and Clinical Practice. 2003 August; 61(2): 133-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12951282

•Diabetic retinopathy in Oman: a hospital based study.

Author(s): Khandekar R, Al Lawatii J, Mohammed AJ, Al Raisi A.

Source: The British Journal of Ophthalmology. 2003 September; 87(9): 1061-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12928265

•Diabetic retinopathy with repeated amaurosis fugax caused by orthostatic hypotension.

Author(s): Mimura T, Funatsu H, Kitano S, Amano S, Haruyama K, Shimizu E, Araie M, Hori S.

Source: American Journal of Ophthalmology. 2003 November; 136(5): 930-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14597053

•Diabetic retinopathy.

Author(s): Stefansson E.

Source: The New England Journal of Medicine. 2004 June 10; 350(24): 2525-6; Author Reply 2525-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15190152

•Diabetic retinopathy.

Author(s): Grassi G.

Source: Minerva Med. 2003 December; 94(6): 419-35. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14976470

•Diabetic retinopathy.

Author(s): Frank RN.

Source: The New England Journal of Medicine. 2004 January 1; 350(1): 48-58. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14702427

•Diabetic retinopathy: management update.

Author(s): Nwosu SN.

Source: Niger Postgrad Med J. 2003 June; 10(2): 115-20. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14567050

82 Diabetic Retinopathy

•Diabetic retinopathy: medical management and assessment.

Author(s): Delli Castelli M, Leslie RD.

Source: Hosp Med. 2003 July; 64(7): 400-3. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12886849

•Diabetic retinopathy: should this patient receive laser treatment?

Author(s): Chew EY, Dowler J, Flynn H.

Source: The British Journal of Ophthalmology. 2004 March; 88(3): 433. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14977783

•Diabetic retinopathy: should this patient receive laser treatment? Overview.

Author(s): Chew E.

Source: The British Journal of Ophthalmology. 2004 March; 88(3): 436-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14977786

•Diabetic retinopathy: yet another reason for a comprehensive eye-care programme for Australian Aborigines and Torres Strait Islanders.

Author(s): McCarty CA.

Source: Clinical & Experimental Ophthalmology. 2003 February; 31(1): 6-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12580887

•Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.

Author(s): Harada C, Harada T, Mitamura Y, Quah HM, Ohtsuka K, Kotake S, Ohno S, Wada K, Takeuchi S, Tanaka K.

Source: Molecular Vision [electronic Resource]. 2004 January 15; 10: 31-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14737065

•Does pregnancy accelerate the rate of progression of diabetic retinopathy?

Author(s): Sheth BP.

Source: Curr Diab Rep. 2002 August; 2(4): 327-30. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12643192

•Early complement activation and decreased levels of glycosylphosphatidylinositolanchored complement inhibitors in human and experimental diabetic retinopathy.

Author(s): Zhang J, Gerhardinger C, Lorenzi M. Source: Diabetes. 2002 December; 51(12): 3499-504.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12453906

Studies 83

•Early improvement of unstable diabetic retinopathy after solitary pancreas transplantation.

Author(s): Giannarelli R, Coppelli A, Sartini MS, Aragona M, Boggi U, Mosca F, Nardi M, Del Prato S, Marchetti P.

Source: Diabetes Care. 2002 December; 25(12): 2358-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12453991

•Effect of a growth hormone receptor antagonist on proliferative diabetic retinopathy.

Author(s): Chantelau E.

Source: Ophthalmology. 2002 December; 109(12): 2187; Author Reply 2187-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12466154

•Effect of video display on the grading of diabetic retinopathy.

Author(s): Costen MT, Newsom RS, Parkin B, Marsh CS, Mehta RL, Luff AJ, Canning CR.

Source: Eye (London, England). 2004 February; 18(2): 169-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14762410

•Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields.

Author(s): Boucher MC, Gresset JA, Angioi K, Olivier S. Source: Can J Ophthalmol. 2003 December; 38(7): 557-68.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14740797

•Efficacy and reliability of fundus digital camera as a screening tool for diabetic retinopathy in Kuwait.

Author(s): Al Sabti K, Raizada S, Wani VB, Al Ajmi M, Gayed I, Sugathan TN. Source: Journal of Diabetes and Its Complications. 2003 July-August; 17(4): 229-33.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12810247

•Elevated adrenomedullin in the vitreous of patients with diabetic retinopathy.

Author(s): Ito S, Fujisawa K, Sakamoto T, Ishibashi T.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2003 January-February; 217(1): 53-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12566874

•Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

Author(s): Ambati J, Chalam KV, Chawla DK, D'Angio CT, Guillet EG, Rose SJ, Vanderlinde RE, Ambati BK.

Source: Archives of Ophthalmology. 1997 September; 115(9): 1161-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9298058

84 Diabetic Retinopathy

•Entoptic foveal avascular zone measurement and diabetic retinopathy.

Author(s): Hilmantel G, Applegate RA, van Heuven WA, Stowers SP, Bradley A, Lee BL.

Source: Optometry and Vision Science : Official Publication of the American Academy of Optometry. 1999 December; 76(12): 826-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10612403

•Epidemiology of diabetic retinopathy.

Author(s): Chew EY.

Source: Hosp Med. 2003 July; 64(7): 396-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12886848

•Evaluating the management of diabetic retinopathy in a teaching center.

Author(s): Pharmakakis NM, Petropoulos IK, Peristeropoulos PA, Vantzou CV, Koliopoulos JX.

Source: Eur J Ophthalmol. 2002 November-December; 12(6): 488-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12516532

•Evaluation of a district-wide screening programme for diabetic retinopathy utilizing trained optometrists using slit-lamp and Volk lenses.

Author(s): Hulme SA, Tin-U A, Hardy KJ, Joyce PW.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2002 September; 19(9): 741-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12207810

•Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy.

Author(s): Massin P, Erginay A, Ben Mehidi A, Vicaut E, Quentel G, Victor Z, Marre M, Guillausseau PJ, Gaudric A.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 August; 20(8): 635-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12873290

•Evaluation of retinal nerve fiber layer thickness in diabetic retinopathy after panretinal photocoagulation.

Author(s): Hsu SY, Chung CP.

Source: Kaohsiung J Med Sci. 2002 August; 18(8): 397-400. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12476683

•Evidence for photoreceptor changes in patients with diabetic retinopathy.

Author(s): Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE.

Source: Investigative Ophthalmology & Visual Science. 1997 October; 38(11): 2355-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9344359

Studies 85

•Exercise training in individuals with diabetic retinopathy and blindness.

Author(s): Bernbaum M, Albert SG, Cohen JD.

Source: Archives of Physical Medicine and Rehabilitation. 1989 August; 70(8): 605-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2764690

•Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Author(s): Klein BE, Klein R, Moss SE.

Source: Diabetes Care. 1999 December; 22(12): 1984-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10587830

•Extracts from "concise clinical evidence". Commentary: treatment of diabetic retinopathy.

Author(s): Kohner E.

Source: Bmj (Clinical Research Ed.). 2003 May 10; 326(7397): 1023-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12742899

•Extracts from "concise clinical evidence". Diabetic retinopathy.

Author(s): Harding S.

Source: Bmj (Clinical Research Ed.). 2003 May 10; 326(7397): 1023-5. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12742927

•Exudative age-related macular degeneration in patients with diabetic retinopathy and its relation to retinal laser photocoagulation.

Author(s): Zylbermann R, Landau D, Rozenman Y, Abrahami S, Pollack A. Source: Eye (London, England). 1997; 11 ( Pt 6): 872-5.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9537150

•Factors that influence the decision to receive treatment for proliferative diabetic retinopathy.

Author(s): Reno PL, Arfken CL, Heins JM, Fisher EB Jr. Source: Diabetes Educ. 1997 November-December; 23(6): 653-5.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9416028

•Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients.

Author(s): Rema M, Saravanan G, Deepa R, Mohan V.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2002 November; 19(11): 910-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12421427

86 Diabetic Retinopathy

•Fas-mediated apoptosis in human lens epithelial cells of cataracts associated with diabetic retinopathy.

Author(s): Okamura N, Ito Y, Shibata MA, Ikeda T, Otsuki Y.

Source: Medical Electron Microscopy : Official Journal of the Clinical Electron Microscopy Society of Japan. 2002 December; 35(4): 234-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12658358

•Fatty acid binding protein gene 2 polymorphism is not associated with diabetic retinopathy in Japanese type 2 diabetic patients.

Author(s): Yoshioka K, Yoshida T, Takakura Y, Umekawa T, Kogure A, Toda H, Yoshikawa T.

Source: Hormone and Metabolic Research. HormonUnd Stoffwechselforschung. Hormones Et Metabolisme. 2003 October; 35(10): 625-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14605999

•Fetal weight and progression of diabetic retinopathy.

Author(s): McElvy SS, Demarini S, Miodovnik M, Khoury JC, Rosenn B, Tsang RC. Source: Obstetrics and Gynecology. 2001 April; 97(4): 587-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11275032

•Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project.

Author(s): McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA.

Source: Clinical & Experimental Ophthalmology. 2003 October; 31(5): 397-402. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14516426

•Florid diabetic retinopathy (FDR): a long-term follow-up study.

Author(s): Lattanzio R, Brancato R, Bandello FM, Azzolini C, Malegori A, Maestranzi G. Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2001 March; 239(3): 182-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11405067

•Florid diabetic retinopathy and its systemic implications.

Author(s): Lanzetta P, Bandello F, Menchini U, Brancato R.

Source: Diabetes Nutr Metab. 1999 December; 12(6): 418-9. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10782564

•Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy.

Author(s): Yang G, Qiu H, Wang S, Deng H, Zhang S, Li L. Source: Zhonghua Yi Xue Za Zhi (Taipei). 2000 May; 63(5): 407-12.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10862451

Studies 87

•Fluorescein angiography of extreme peripheral retina and rubeosis iridis in proliferative diabetic retinopathy.

Author(s): Terasaki H, Miyake Y, Mori M, Suzuki T, Kondo M. Source: Retina (Philadelphia, Pa.). 1999; 19(4): 302-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10458295

•Foreword: Evaluation of new treatment paradigms for diabetic retinopathy and macular edema.

Author(s): Ferris FL 3rd.

Source: Survey of Ophthalmology. 2002 December; 47 Suppl 2: S237. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12507624

•Foveal cone function in nonproliferative diabetic retinopathy and macular edema.

Author(s): Weiner A, Christopoulos VA, Gussler CH, Adams DH, Kaufman SR, Kohn HD, Weidenthal DT.

Source: Investigative Ophthalmology & Visual Science. 1997 June; 38(7): 1443-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9191608

•Foveal haemorrhages in diabetic retinopathy. Clinical characteristics and visual outcome.

Author(s): Lahrmann C, Bek T.

Source: Acta Ophthalmologica Scandinavica. 2000 April; 78(2): 169-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10794250

•Fractal dimension in diabetic retinopathy.

Author(s): Hesse L.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1994 July; 232(7): 447-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7926879

•Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.

Author(s): Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW. Source: The Journal of Clinical Endocrinology and Metabolism. 1997 September; 82(9): 2809-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9284701

88 Diabetic Retinopathy

•Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

Author(s): Simo R, Lecube A, Segura RM, Garcia Arumi J, Hernandez C. Source: American Journal of Ophthalmology. 2002 September; 134(3): 376-82.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12208249

•Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.

Author(s): Simo R, Hernandez C, Segura RM, Garcia-Arumi J, Sararols L, Burgos R, Canton A, Mesa J.

Source: Clinical Science (London, England : 1979). 2003 March; 104(3): 223-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12605576

•Frequency and patients' reported awareness of diabetic retinopathy among type 2 diabetic patients admitted to internal medicine wards.

Author(s): Sadeh AD, Rosenblatt I, Rosenberger Y, Lazar M, Loewenstein A. Source: Diabetes Care. 2000 September; 23(9): 1436-7.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10977051

•From minimal background diabetic retinopathy to profuse sight threatening vitreoretinal haemorrhage: management issues in a case of pregestational diabetes and pregnancy.

Author(s): Chatterjee S, Tsaloumas MD, Gee H, Lipkin G, Dunne FP.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 August; 20(8): 683-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12873299

•Functions of insulin and insulin receptor signaling in retina: possible implications for diabetic retinopathy.

Author(s): Reiter CE, Gardner TW.

Source: Progress in Retinal and Eye Research. 2003 July; 22(4): 545-62. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12742394

•General practitioners are the most important conveyors of information to their patients regarding diabetic retinopathy.

Author(s): Livingston PM, Wood CA, Butler M, Oh J, Keefe JE, Taylor HR. Source: Diabetes Care. 1998 February; 21(2): 324-5.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9540007

•Genes and diabetic retinopathy.

Author(s): Radha V, Rema M, Mohan V.

Source: Indian J Ophthalmol. 2002 March; 50(1): 5-11. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12090088

Studies 89

•Genetic markers in early diabetic retinopathy of adolescents with type I diabetes.

Author(s): Falck AA, Knip JM, Ilonen JS, Laatikainen LT.

Source: Journal of Diabetes and Its Complications. 1997 July-August; 11(4): 203-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9201596

•Genetic risk factors in diabetic retinopathy.

Author(s): Stewart LL, Field LL, Ross S, McArthur RG. Source: Diabetologia. 1993 December; 36(12): 1293-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8307258

•Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy.

Author(s): Warpeha KM, Xu W, Liu L, Charles IG, Patterson CC, Ah-Fat F, Harding S, Hart PM, Chakravarthy U, Hughes AE.

Source: The Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology. 1999 October; 13(13): 1825-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10506586

•Glial cell involvement in vascular occlusion of diabetic retinopathy.

Author(s): Bek T.

Source: Acta Ophthalmologica Scandinavica. 1997 June; 75(3): 239-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9253965

•Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.

Author(s): Liu QZ, Pettitt DJ, Hanson RL, Charles MA, Klein R, Bennett PH, Knowler WC.

Source: Diabetologia. 1993 May; 36(5): 428-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8314447

•Glycoprotein deposition in vascular walls of diabetic retinopathy. A histopathological and immunohistochemical study.

Author(s): Bek T, Ledet T.

Source: Acta Ophthalmologica Scandinavica. 1996 August; 74(4): 385-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8883556

•Glycosylated hemoglobin and diabetic retinopathy.

Author(s): Singh R, Prakash V, Shukla PK, Gautam S, Maurya OP. Source: Ann Ophthalmol. 1991 August; 23(8): 308-11.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1952641

90 Diabetic Retinopathy

•Graded corneal sensitivity for screening of diabetic retinopathy.

Author(s): Saini JS, Mittal S.

Source: Indian J Ophthalmol. 1996 December; 44(4): 219-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9251266

•Grading and disease management in national screening for diabetic retinopathy in England and Wales.

Author(s): Harding S, Greenwood R, Aldington S, Gibson J, Owens D, Taylor R, Kohner E, Scanlon P, Leese G; Diabetic Retinopathy Grading and Disease Management Working Party.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 December; 20(12): 965-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14632697

•Grading diabetic retinopathy from a computer screen.

Author(s): Leverton C.

Source: The Journal of Audiovisual Media in Medicine. 1996 December; 19(4): 176. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9136176

•Gray-white, spherical deposition on retinal vessel associated with acute retinal necrosis and diabetic retinopathy in HTLV-I carriers.

Author(s): Nakao K, Ohba N, Uemura A, Okubo A, Sameshima M, Hayami K. Source: Japanese Journal of Ophthalmology. 1998 November-December; 42(6): 490-4.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9886741

•Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.

Author(s): Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H. Source: Diabetes. 1997 September; 46 Suppl 2: S26-30. Review.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9285495

•Growth factors and diabetic retinopathy.

Author(s): Paques M, Massin P, Gaudric A.

Source: Diabetes & Metabolism. 1997 April; 23(2): 125-30. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9137900

•Growth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy.

Author(s): Aiello LP, Cahill MT, Cavallerano JD.

Source: Eye (London, England). 2004 February; 18(2): 117-25. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14762400

Studies 91

•Growth factors in proliferative diabetic retinopathy.

Author(s): Khan ZA, Chakrabarti S.

Source: Experimental Diabesity Research. 2003 October-December; 4(4): 287-301. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14668050

•Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration.

Author(s): Wiedemann P.

Source: Survey of Ophthalmology. 1992 March-April; 36(5): 373-84. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1566240

•Growth hormone suppression and nonproliferative diabetic retinopathy: a preliminary feasibility study.

Author(s): Shumak SL, Grossman LD, Chew E, Kozousek V, George SR, Singer W, Harris AG, Zinman B.

Source: Clinical and Investigative Medicine. Medecine Clinique Et Experimentale. 1990 October; 13(5): 287-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2276223

•Guidelines for screening for diabetic retinopathy revisited.

Author(s): Klein R.

Source: Ophthalmic Epidemiology. 1999 March; 6(1): 1-4. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10384679

•Haptoglobin genotype as a risk factor for diabetic retinopathy.

Author(s): Nakhoul FM, Marsh S, Hochberg I, Leibu R, Miller BP, Levy AP.

Source: Jama : the Journal of the American Medical Association. 2000 September 13; 284(10): 1244-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10979109

•Has the frequency of proliferative diabetic retinopathy declined in the US?

Author(s): Klein R.

Source: Diabetes Care. 2003 September; 26(9): 2691-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12941740

•Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria.

Author(s): Imano E, Miyatsuka T, Motomura M, Kanda T, Matsuhisa M, Kajimoto Y, Yamasaki Y, Hori M.

Source: Diabetes Research and Clinical Practice. 2001 June; 52(3): 185-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11323088

92 Diabetic Retinopathy

•Hemodynamic alterations in diabetic retinopathy.

Author(s): Guven D, Ozdemir H, Hasanreisoglu B. Source: Ophthalmology. 1996 August; 103(8): 1245-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8764795

•Hemorheological alterations in patients with diabetic retinopathy.

Author(s): Vekasi J, Marton ZS, Kesmarky G, Cser A, Russai R, Horvath B. Source: Clinical Hemorheology and Microcirculation. 2001; 24(1): 59-64.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11345235

•Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.

Author(s): Canton A, Burgos R, Hernandez C, Mateo C, Segura RM, Mesa J, Simo R. Source: The British Journal of Ophthalmology. 2000 July; 84(7): 732-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10873984

•Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.

Author(s): Katsura Y, Okano T, Noritake M, Kosano H, Nishigori H, Kado S, Matsuoka T.

Source: Diabetes Care. 1998 October; 21(10): 1759-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9773744

•High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy.

Author(s): Rajala U, Pajunpaa H, Koskela P, Keinanen-Kiukaanniemi S. Source: Diabetes Care. 2000 July; 23(7): 957-61.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10895846

•High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.

Author(s): Kim CH, Park HJ, Park JY, Hong SK, Yoon YH, Lee KU. Source: Diabetes Care. 1998 December; 21(12): 2149-51.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9839109

•Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels.

Author(s): Cusick M, Chew EY, Chan CC, Kruth HS, Murphy RP, Ferris FL 3rd. Source: Ophthalmology. 2003 November; 110(11): 2126-33.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14597519

Studies 93

•HLA typing is not predictive of proliferative diabetic retinopathy in patients with younger onset type 2 diabetes mellitus.

Author(s): Mimura T, Amano S, Kato S, Araie M, Funatsu H, Kitano S, Shimizu E, Noma H, Yoshino O, Hori S.

Source: The British Journal of Ophthalmology. 2004 February; 88(2): 303-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14736798

•HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy.

Author(s): Wong TY, Cruickshank KJ, Klein R, Klein BE, Moss SE, Palta M, Riley WJ, Maclaren NK, Vadheim CM, Rotter JI.

Source: Ophthalmology. 2002 February; 109(2): 275-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11825808

•Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy.

Author(s): Chiarelli F, Pomilio M, Mohn A, Tumini S, Vanelli M, Morgese G, Spagnoli A, Verrotti A.

Source: The Journal of Pediatrics. 2000 September; 137(3): 386-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10969265

•How effective is the referral chain for diabetic retinopathy?

Author(s): Jenkins L, Knight AH, Mayon-White V.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 1989 September-October; 6(7): 645. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2527713

•How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy.

Author(s): Klein R, Klein BE, Moss SE.

Source: Archives of Ophthalmology. 2001 April; 119(4): 547-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11296020

•Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy.

Author(s): Ljubimov AV, Huang ZS, Huang GH, Burgeson RE, Gullberg D, Miner JH, Ninomiya Y, Sado Y, Kenney MC.

Source: The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 1998 September; 46(9): 1033-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9705969

94 Diabetic Retinopathy

•Human vitreal prostaglandin levels and proliferative diabetic retinopathy.

Author(s): Douros S, Phillips BA, Nadel A, Obstbaum SA.

Source: Documenta Ophthalmologica. Advances in Ophthalmology. 2001 July; 103(1): 27-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11678158

•Hyperlipidemia, insulin-dependent diabetes mellitus, and rapidly progressive diabetic retinopathy and nephropathy in Prader-Willi syndrome with del(15)(q11.2q13).

Author(s): Bassali R, Hoffman WH, Chen H, Tuck-Muller CM.

Source: American Journal of Medical Genetics. 1997 August 22; 71(3): 267-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9268093

•Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

Author(s): Harris A, Arend O, Danis RP, Evans D, Wolf S, Martin BJ. Source: The British Journal of Ophthalmology. 1996 March; 80(3): 209-13.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8703857

•Hypertension and diabetic retinopathy--what's the story?

Author(s): Gillow JT, Gibson JM, Dodson PM.

Source: The British Journal of Ophthalmology. 1999 September; 83(9): 1083-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10460781

•Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model.

Author(s): Bachmann MO, Nelson SJ.

Source: Journal of Epidemiology and Community Health. 1998 January; 52(1): 45-52. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9604041

•Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15.

Author(s): Fong DS, Barton FB, Bresnick GH.

Source: American Journal of Ophthalmology. 1999 November; 128(5): 612-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10577530

•Improving diabetic retinopathy screening.

Author(s): Jackson W.

Source: Diabetes Care. 2002 August; 25(8): 1477-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12145254

Studies 95

•Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado.

Author(s): Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM. Source: Diabetes Care. 1998 January; 21(1): 53-61.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9538971

•Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran.

Author(s): Janghorbani M, Amini M, Ghanbari H, Safaiee H. Source: Ophthalmic Epidemiology. 2003 April; 10(2): 81-95.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12660857

•Incidence of diabetic retinopathy in the Barbados Eye Studies.

Author(s): Leske MC, Wu SY, Hennis A, Nemesure B, Hyman L, Schachat A; Barbados Eye Studies Group.

Source: Ophthalmology. 2003 May; 110(5): 941-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12750094

•Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.

Author(s): Nakamura N, Hasegawa G, Obayashi H, Yamazaki M, Ogata M, Nakano K, Yoshikawa T, Watanabe A, Kinoshita S, Fujinami A, Ohta M, Imamura Y, Ikeda T. Source: Diabetes Research and Clinical Practice. 2003 August; 61(2): 93-101. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12951277

•Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy.

Author(s): Lauszus FF, Klebe JG, Bek T, Flyvbjerg A. Source: Diabetes. 2003 March; 52(3): 852-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12606530

•Influence of successful pancreaticorenal transplantation on diabetic retinopathy.

Author(s): Caldara R, Bandello F, Vigano C, Secchi A, Castoldi R, Caldi M, Di Carlo V, Torri G, Pozza G, Brancato R.

Source: Transplantation Proceedings. 1994 April; 26(2): 490. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8171518

•Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes.

Author(s): Globocnik-Petrovic M, Hawlina M, Peterlin B, Petrovic D.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2003 May-June; 217(3): 219-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12660488

96 Diabetic Retinopathy

•Instant electronic imaging systems are superior to Polaroid at detecting sightthreatening diabetic retinopathy.

Author(s): Ryder RE, Kong N, Bates AS, Sim J, Welch J, Kritzinger EE.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 1998 March; 15(3): 254-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9545128

•Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.

Author(s): Leibovitch I, Loewenstein A, Alster Y, Rosenblatt I, Lazar M, Yassur Y, Rubinstein A.

Source: Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye. 2004 January-February; 35(1): 16-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14750758

•Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.

Author(s): Cicik E, Tekin H, Akar S, Ekmekci OB, Donma O, Koldas L, Ozkan S. Source: Ophthalmic Research. 2003 September-October; 35(5): 251-5.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12920337

•Inter-observer comparisons of ophthalmoscopic assessment of diabetic retinopathy.

Author(s): Lienert RT.

Source: Australian and New Zealand Journal of Ophthalmology. 1989 November; 17(4): 363-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2624726

•Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.

Author(s): Jonas JB, Sofker A, Degenring R. Source: Eur J Ophthalmol. 2003 June; 13(5): 468-73.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12841570

•Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy.

Author(s): Hernandez C, Lecube A, Castellanos JM, Segura RM, Garat M, Garcia-Arumi J, Simo R.

Source: Retina (Philadelphia, Pa.). 2004 February; 24(1): 30-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15076941

Studies 97

•Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?

Author(s): Klein R, Klein BE, Moss SE, Davis MD, DeMets DL.

Source: Archives of Internal Medicine. 1989 November; 149(11): 2427-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2684072

•Is digital image compression acceptable within diabetic retinopathy screening?

Author(s): Basu A, Kamal AD, Illahi W, Khan M, Stavrou P, Ryder RE.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 September; 20(9): 766-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12925059

•Is medical treatment for diabetic retinopathy still an unreal dream?

Author(s): Giusti C.

Source: Medical Hypotheses. 2002 December; 59(6): 706-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12445513

•Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger-onset diabetes of long duration?

Author(s): Klein BE, Klein R, Moss SE.

Source: American Journal of Ophthalmology. 1999 November; 128(5): 652-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10577544

•Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy.

Author(s): Ma JX, King LP, Yang Z, Crouch RK, Chao L, Chao J. Source: Current Eye Research. 1996 November; 15(11): 1117-23.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8950506

•Keeping good vision with diabetic retinopathy: a nursing responsibility.

Author(s): Smith SS.

Source: The Abnf Journal : Official Journal of the Association of Black Nursing Faculty in Higher Education, Inc. 1996 May-June; 7(3): 81-4. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8826167

•Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study.

Author(s): Singerman LJ, Ferris FL 3rd, Mowery RP, Brucker AJ, Murphy RP, Lerner BC, Mincey GJ.

Source: J Diabet Complications. 1988 October-December; 2(4): 189-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2466855

98 Diabetic Retinopathy

•Lack of association between the heparan sulfate proteoglycan gene polymorphism and diabetic nephropathy in Japanese NIDDM with proliferative diabetic retinopathy.

Author(s): Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K, Ito S. Source: Renal Failure. 1999 November; 21(6): 659-64.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10586428

•Laser management of diabetic retinopathy.

Author(s): Dowler JG.

Source: Journal of the Royal Society of Medicine. 2003 June; 96(6): 277-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12782691

•Lasers and diabetic retinopathy: the art of gentle destruction.

Author(s): Petrovic V, Bhisitkul RB.

Source: Diabetes Technology & Therapeutics. 1999 Summer; 1(2): 177-87. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11475290

•Life expectancy and diabetic retinopathy.

Author(s): Kirstein MD.

Source: J Am Optom Assoc. 1989 July; 60(7): 503. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2760393

•Lipid peroxidation and diabetic retinopathy.

Author(s): Kumar RS, Anthrayose CV, Iyer KV, Vimala B, Shashidhar S. Source: Indian Journal of Medical Sciences. 2001 March; 55(3): 133-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11482166

•Lipoprotein(a) as an independent risk factor for diabetic retinopathy in male patients in non-insulin-dependent diabetes mellitus.

Author(s): Onuma T, Kikuchi T, Shimura M, Tsutsui M, Matsui J, Boku A, Takebe K. Source: The Tohoku Journal of Experimental Medicine. 1994 June; 173(2): 209-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7817385

•Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima indians.

Author(s): Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Source: Diabetes Care. 2003 February; 26(2): 320-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12547856

Studies 99

•Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme.

Author(s): Ling R, Ramsewak V, Taylor D, Jacob J. Source: Eye (London, England). 2002 March; 16(2): 140-5.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11988813

•Long-term glycaemic control and diabetic retinopathy.

Author(s): McCance DR, Hadden DR, Atkinson AB, Archer DB, Kennedy L. Source: Lancet. 1989 October 7; 2(8667): 824-8.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2571758

•Long-term metabolic control and diabetic retinopathy.

Author(s): McNally PG, Swift P, Burden AC, Hearnshaw JR. Source: Lancet. 1989 November 18; 2(8673): 1227.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2572943

•Loss of myelinated retinal nerve fibres in diabetic retinopathy.

Author(s): Gentile RC, Torqueti-Costa L, Bertolucci A.

Source: The British Journal of Ophthalmology. 2002 December; 86(12): 1447. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12446391

•Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.

Author(s): Boehm BO, Lang G, Volpert O, Jehle PM, Kurkhaus A, Rosinger S, Lang GK, Bouck N.

Source: Diabetologia. 2003 March; 46(3): 394-400. Epub 2003 March 01. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12687338

•Macular recovery during onset and development of diabetic retinopathy in childhood and adolescence.

Author(s): Frost-Larsen K, Lund-Anderson C, Starup K. Source: Acta Ophthalmol (Copenh). 1989 August; 67(4): 401-4.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2801042

•Massive subretinal bleed in a patient with background diabetic retinopathy and on treatment with warfarin.

Author(s): Raj A, Sekhri R, Salam A, Priya P.

Source: Eye (London, England). 2003 July; 17(5): 649-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12855977

100 Diabetic Retinopathy

•Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy.

Author(s): Lund-Andersen H.

Source: Survey of Ophthalmology. 2002 December; 47 Suppl 2: S270-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12507629

•Medical treatment of diabetic retinopathy.

Author(s): Donaldson M, Dodson PM.

Source: Eye (London, England). 2003 July; 17(5): 550-62. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12855958

•Midterm visual outcome and progression of diabetic retinopathy following cataract surgery. Midterm outcome of cataract surgery in diabetes.

Author(s): Schrey S, Krepler K, Biowski R, Wedrich A.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2002 September-October; 216(5): 337-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12424399

•Molecular genetics of microvascular disease in diabetic retinopathy.

Author(s): Warpeha KM, Chakravarthy U.

Source: Eye (London, England). 2003 April; 17(3): 305-11. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12724690

•Molecular mechanisms of retinal neovascularization in diabetic retinopathy.

Author(s): Takagi H.

Source: Intern Med. 2003 March; 42(3): 299-301. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12705804

•MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation.

Author(s): Maeda M, Yamamoto I, Fukuda M, Nishida M, Fujitsu J, Nonen S, Igarashi T, Motomura T, Inaba M, Fujio Y, Azuma J.

Source: Diabetes Care. 2003 February; 26(2): 547-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12547903

•Muller cell changes in human diabetic retinopathy.

Author(s): Mizutani M, Gerhardinger C, Lorenzi M. Source: Diabetes. 1998 March; 47(3): 445-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9519752

Studies 101

•Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy.

Author(s): Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Source: Investigative Ophthalmology & Visual Science. 2004 March; 45(3): 948-54.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14985316

•National screening for diabetic retinopathy: clear vision needed.

Author(s): Mason J.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 December; 20(12): 959-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14632695

•National screening programme for diabetic retinopathy. Staff are already available to do this job.

Author(s): Broughton R.

Source: Bmj (Clinical Research Ed.). 2001 October 27; 323(7319): 999. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12141321

•Neurotrophic factor receptors in epiretinal membranes after human diabetic retinopathy.

Author(s): Harada T, Harada C, Mitamura Y, Akazawa C, Ohtsuka K, Ohno S, Takeuchi S, Wada K.

Source: Diabetes Care. 2002 June; 25(6): 1060-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12032115

•NF-kappaB in epiretinal membranes after human diabetic retinopathy.

Author(s): Mitamura Y, Harada T, Harada C, Ohtsuka K, Kotake S, Ohno S, Tanaka K, Takeuchi S, Wada K.

Source: Diabetologia. 2003 May; 46(5): 699-703. Epub 2003 May 13. Erratum In: Diabetologia. 2003 October; 46(10): 1446. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12743697

•Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy.

Author(s): Hernandez C, Lecube A, Segura RM, Sararols L, Simo R.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2002 August; 19(8): 655-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12147146

102 Diabetic Retinopathy

•No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy.

Author(s): Yoshioka K, Yoshida T, Takakura Y, Kogure A, Umekawa T, Toda H, Yoshikawa T.

Source: Diabetes Care. 2003 June; 26(6): 1947-8; Author Reply 1948. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12766148

•Non-stereo fundus photography as a screening procedure for diabetic retinopathy among patients with type II diabetes. Compared with 60D enhanced slit-lamp examination.

Author(s): Kalm H, Egertsen R, Blohme G.

Source: Acta Ophthalmol (Copenh). 1989 October; 67(5): 546-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2589054

•Non-stereo photographic screening after panretinal photocoagulation for proliferative diabetic retinopathy. Compared with 60D enhanced slit-lamp examination.

Author(s): Kalm H, Sjodell L, Jonsson R.

Source: Acta Ophthalmol (Copenh). 1989 October; 67(5): 554-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2589055

•Novel diagnostic and therapeutic approaches to the diabetic retinopathy.

Author(s): Giusti C.

Source: Eur Rev Med Pharmacol Sci. 2001 September-December; 5(5-6): 155-66. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12201666

•Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery.

Author(s): Hauser D, Katz H, Pokroy R, Bukelman A, Shechtman E, Pollack A. Source: Journal of Cataract and Refractive Surgery. 2004 February; 30(2): 428-32.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15030836

•Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy.

Author(s): Boehm BO, Lang GK, Jehle PM, Feldman B, Lang GE.

Source: Hormone and Metabolic Research. HormonUnd Stoffwechselforschung. Hormones Et Metabolisme. 2001 May; 33(5): 300-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11440277

•Ocular blood flow and associated functional deviations in diabetic retinopathy.

Author(s): Schmetterer L, Wolzt M.

Source: Diabetologia. 1999 April; 42(4): 387-405. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10230642

Studies 103

•Ocular blood flow parameters after pars plana vitrectomy in patients with diabetic retinopathy.

Author(s): Krepler K, Polska E, Wedrich A, Schmetterer L. Source: Retina (Philadelphia, Pa.). 2003 April; 23(2): 192-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12707598

•Ocular blood flow velocities in patients with proliferative diabetic retinopathy after panretinal photocoagulation.

Author(s): Mendivil A.

Source: Survey of Ophthalmology. 1997 November; 42 Suppl 1: S89-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9603294

•Oncofetal fibronectin in diabetic retinopathy.

Author(s): Khan ZA, Cukiernik M, Gonder JR, Chakrabarti S.

Source: Investigative Ophthalmology & Visual Science. 2004 January; 45(1): 287-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14691186

•One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.

Author(s): Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ, Maguire AM, Ho AC, Fine SL.

Source: American Journal of Ophthalmology. 2000 February; 129(2): 178-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10682970

•Ophthaproblem. Diabetic retinopathy.

Author(s): Sharma S.

Source: Can Fam Physician. 1999 February; 45: 295, 304. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10065299

•Optical coherence tomography of tractional macular elevations in eyes with proliferative diabetic retinopathy.

Author(s): Imai M, Iijima H, Hanada N.

Source: American Journal of Ophthalmology. 2001 September; 132(3): 458-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11530091

•Optical coherence tomography of tractional macular elevations in eyes with proliferative diabetic retinopathy.

Author(s): Imai M, Iijima H, Hanada N.

Source: American Journal of Ophthalmology. 2001 July; 132(1): 81-4. Corrected and Republished In: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11438058

104 Diabetic Retinopathy

•Pathogenesis of diabetic retinopathy and the renin-angiotensin system.

Author(s): Funatsu H, Yamashita H.

Source: Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists). 2003 November; 23(6): 495-501. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14622351

•Perspectives on diabetic retinopathy.

Author(s): Polak BC, Dekker JM, Moll AC, Van Leiden HA.

Source: American Journal of Ophthalmology. 2003 December; 136(6): 1193; Author Reply 1193. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14644255

•Pharmacologic therapy for diabetic retinopathy.

Author(s): Speicher MA, Danis RP, Criswell M, Pratt L.

Source: Expert Opinion on Emerging Drugs. 2003 May; 8(1): 239-50. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14610924

•Platelet activation in patients with diabetic retinopathy.

Author(s): Bae SH, Lee J, Roh KH, Kim J.

Source: Korean J Ophthalmol. 2003 December; 17(2): 140-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14717493

•Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy.

Author(s): Amano S, Yamagishi S, Koda Y, Tsuneoka M, Soejima M, Okamoto T, Inagaki Y, Yamada K, Kimura H.

Source: Medical Hypotheses. 2003 April; 60(4): 550-1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12615520

•Potential new strategies to prevent the development of diabetic retinopathy.

Author(s): Mohr S.

Source: Expert Opinion on Investigational Drugs. 2004 March; 13(3): 189-98. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15013939

•Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients.

Author(s): Rotimi C, Daniel H, Zhou J, Obisesan A, Chen G, Chen Y, Amoah A, Opoku V, Acheampong J, Agyenim-Boateng K, Eghan BA Jr, Oli J, Okafor G, Ofoegbu E, Osotimehin B, Abbiyesuku F, Johnson T, Fasanmade O, Doumatey A, Aje T, Collins F, Dunston G.

Source: Ethn Dis. 2003 Summer; 13(2 Suppl 2): S110-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=13677425

Studies 105

•Prevalence of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 1.

Author(s): Jaross N, Ryan P, Newland H.

Source: Clinical & Experimental Ophthalmology. 2003 February; 31(1): 32-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12580891

•Progression of diabetic retinopathy after phacoemulsification in diabetic patients: a three-year analysis.

Author(s): Liao SB, Ku WC.

Source: Chang Gung Med J. 2003 November; 26(11): 829-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14765753

•Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.

Author(s): Donnelly R, Idris I, Forrester JV.

Source: The British Journal of Ophthalmology. 2004 January; 88(1): 145-51. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14693793

•Quality assurance in screening for sight-threatening diabetic retinopathy.

Author(s): Pandit RJ, Taylor R.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2002 April; 19(4): 285-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11942999

•Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.

Author(s): Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Source: Archives of Ophthalmology. 2002 April; 120(4): 481-4.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11934322

•Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.

Author(s): Shimura M, Yasuda K, Nakazawa T, Kano T, Ohta S, Tamai M. Source: Ophthalmology. 2003 December; 110(12): 2386-94.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14644723

•Quantitation of retinal ablation in proliferative diabetic retinopathy.

Author(s): Reddy VM, Zamora RL, Olk RJ.

Source: American Journal of Ophthalmology. 1995 June; 119(6): 760-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7785691

106 Diabetic Retinopathy

•Quantitative analysis of foveal retinal thickness in diabetic retinopathy with the scanning retinal thickness analyzer.

Author(s): Yasukawa T, Kiryu J, Tsujikawa A, Dong J, Suzuma I, Takagi H, Ogura Y. Source: Retina (Philadelphia, Pa.). 1998; 18(2): 150-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9564696

•Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser.

Author(s): Oshima Y, Emi K, Yamanishi S, Motokura M.

Source: The British Journal of Ophthalmology. 1999 January; 83(1): 54-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10209436

•Quantitative measurement of aqueous flare and aqueous "cells" in eyes with diabetic retinopathy.

Author(s): Kuchle M, Schonherr U, Nguyen NX, Steinhauser B, Naumann GO. Source: Ger J Ophthalmol. 1992; 1(3-4): 164-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1483130

•Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.

Author(s): Noma H, Funatsu H, Yamashita H, Kitano S, Mishima HK, Hori S. Source: Archives of Ophthalmology. 2002 August; 120(8): 1075-80.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12149062

•Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy.

Author(s): Matsumoto Y, Takahashi M, Ogata M.

Source: Japanese Journal of Ophthalmology. 2002 July-August; 46(4): 406-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12225819

•Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old.

Author(s): Cotter SA, Chu RH, Chandler DL, Beck RW, Holmes JM, Rice ML, Hertle RW, Birch EE, Moke PS.

Source: American Journal of Ophthalmology. 2003 October; 136(4): 655-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14516805

•Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human muller cells.

Author(s): Kida T, Ikeda T, Nishimura M, Sugiyama T, Imamura Y, Sotozono C, Nishida K, Kinoshita S, Yoshimura M, Nakamura K, Inokuchi N.

Source: Japanese Journal of Ophthalmology. 2003 January-February; 47(1): 36-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12586176

Studies 107

•Repeatability of an automated Landolt C test, compared with the early treatment of diabetic retinopathy study (ETDRS) chart testing.

Author(s): Ruamviboonsuk P, Tiensuwan M, Kunawut C, Masayaanon P. Source: American Journal of Ophthalmology. 2003 October; 136(4): 662-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14516806

•Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII.

Author(s): Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, Palta M. Source: Ophthalmology. 2003 November; 110(11): 2118-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14597518

•Reversion of 'early worsening' of diabetic retinopathy by deliberate restoration of poor metabolic control.

Author(s): Chantelau E, Meyer-Schwickerath R.

Source: Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 2003 September-October; 217(5): 373-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12913330

•Risk factors for Type II diabetes and diabetic retinopathy in a mexican-american population: Proyecto VER.

Author(s): West SK, Munoz B, Klein R, Broman AT, Sanchez R, Rodriguez J, Snyder R. Source: American Journal of Ophthalmology. 2002 September; 134(3): 390-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12208251

•Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis.

Author(s): Maberley D, Walker H, Koushik A, Cruess A.

Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 2003 January 21; 168(2): 160-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12538543

•Screening for diabetic retinopathy in remote Australia: a program description and evaluation of a devolved model.

Author(s): Mak DB, Plant AJ, McAllister I.

Source: The Australian Journal of Rural Health. 2003 October; 11(5): 224-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14641219

108 Diabetic Retinopathy

•Screening for diabetic retinopathy using the mobile retinal camera: the Waikato experience.

Author(s): Reda E, Dunn P, Straker C, Worsley D, Gross K, Trapski I, Whitcombe S. Source: N Z Med J. 2003 August 22; 116(1180): U562. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14581984

•Screening for diabetic retinopathy, revisited.

Author(s): Klein R, Klein BE.

Source: American Journal of Ophthalmology. 2002 August; 134(2): 261-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12140033

•Screening for diabetic retinopathy: a cause for concern in people who drive.

Author(s): Razvi S, Myers L, Patton K, McCulloch AJ.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2003 October; 20(10): 812-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14510861

•Screening for sight-threatening diabetic retinopathy: comparison of fundus photography with automated color contrast threshold test.

Author(s): Ong GL, Ripley LG, Newsom RS, Cooper M, Casswell AG. Source: American Journal of Ophthalmology. 2004 March; 137(3): 445-52.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15013866

•Sensitivity and specificity of digital retinal images in grading diabetic retinopathy.

Author(s): Saari JM, Summanen P, Kivela T, Saari KM.

Source: Acta Ophthalmologica Scandinavica. 2004 April; 82(2): 126-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15043527

•Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction.

Author(s): Koga K, Yamagishi S, Okamoto T, Inagaki Y, Amano S, Takeuchi M, Makita Z.

Source: Int J Clin Pharmacol Res. 2002; 22(1): 13-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12395914

•Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.

Author(s): Guerci B, Meyer L, Sommer S, George JL, Ziegler O, Drouin P, AngioiDuprez K.

Source: Diabetes & Metabolism. 1999 November; 25(5): 412-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10592864

Studies 109

•Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology.

Author(s): Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Source: Ophthalmology. 2004 May; 111(5): 1055-62. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15121388

•The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design.

Author(s): Chaturvedi N, Sjoelie AK, Svensson A; DIRECT Programme Study Group. Source: J Renin Angiotensin Aldosterone Syst. 2002 December; 3(4): 255-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12584669

•The impact of diabetic retinopathy on participation in daily living.

Author(s): Lamoureux EL, Hassell JB, Keeffe JE.

Source: Archives of Ophthalmology. 2004 January; 122(1): 84-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14718300

•The internist's role in managing diabetic retinopathy: screening for early detection.

Author(s): Sinclair SH, Delvecchio C.

Source: Cleve Clin J Med. 2004 February; 71(2): 151-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14982198

•The management of diabetic retinopathy.

Author(s): Mathews JP, Mathews D, Lavin MJ.

Source: The Practitioner. 2004 January; 248(1654): 34, 38-40, 42 Passim. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14997740

•The pathogenesis of diabetic retinopathy.

Author(s): Stanford MR.

Source: The British Journal of Ophthalmology. 2004 April; 88(4): 444-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15031149

•The potential role of PKC beta in diabetic retinopathy and macular edema.

Author(s): Aiello LP.

Source: Survey of Ophthalmology. 2002 December; 47 Suppl 2: S263-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12507628

•The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States.

Author(s): Roy MS, Klein R, O'Colmain BJ, Klein BE, Moss SE, Kempen JH. Source: Archives of Ophthalmology. 2004 April; 122(4): 546-51.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15078673

110 Diabetic Retinopathy

•The prevalence of diabetic retinopathy among adults in the United States.

Author(s): Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF; Eye Diseases Prevalence Research Group.

Source: Archives of Ophthalmology. 2004 April; 122(4): 552-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=15078674

•Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.

Author(s): Lobo CL, Bernardes RC, Figueira JP, de Abreu JR, Cunha-Vaz JG. Source: Archives of Ophthalmology. 2004 February; 122(2): 211-7.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14769598

•TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.

Author(s): Shah VA, Gupta SK, Shah KV, Vinjamaram S, Chalam KV. Source: Ophthalmic Epidemiology. 2004 February; 11(1): 43-51.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14977496

•Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.

Author(s): Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M. Source: American Journal of Ophthalmology. 2002 September; 134(3): 348-53.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12208245

•Understanding the value of diabetic retinopathy screening.

Author(s): Fong DS, Gottlieb J, Ferris FL 3rd, Klein R.

Source: Archives of Ophthalmology. 2001 May; 119(5): 758-60. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11346406

•United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

Author(s): Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR, Turner RC.

Source: Archives of Ophthalmology. 1998 March; 116(3): 297-303. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9514482

Studies 111

•Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program.

Author(s): Cavallerano AA, Cavallerano JD, Katalinic P, Tolson AM, Aiello LP, Aiello LM; Joslin Vision Network Clinical Team.

Source: Retina (Philadelphia, Pa.). 2003 April; 23(2): 215-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12707602

•Use of oral fluorescein angiography in the diagnosis of macular oedema within a diabetic retinopathy screening programme.

Author(s): Razvi FM, Kritzinger EE, Tsaloumas MD, Ryder RE.

Source: Diabetic Medicine : a Journal of the British Diabetic Association. 2001 December; 18(12): 1003-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11903401

•Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy.

Author(s): Imamura Y, Minami M, Ueki M, Satoh B, Ikeda T.

Source: The British Journal of Ophthalmology. 2003 May; 87(5): 563-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12714393

•Use of telemedicine in periodic screening of diabetic retinopathy.

Author(s): Kawasaki S, Ito S, Satoh S, Mori Y, Saito T, Fukushima H, Kato S, Sekihara H. Source: Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. 2003 Fall; 9(3): 235-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14611690

•Use of telemedicine in screening for diabetic retinopathy.

Author(s): Choremis J, Chow DR.

Source: Can J Ophthalmol. 2003 December; 38(7): 575-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14740799

•Usefulness of corneal esthesiometry for screening diabetic retinopathy.

Author(s): Alvarenga LS, Martins EN, Grottone GT, Morales PH, Paranhos A Jr, Freitas D, Scarpi MJ.

Source: Revista De Saude Publica. 2003 October; 37(5): 609-15. Epub 2003 October 09. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14569337

•Utilities associated with diabetic retinopathy: results from a Canadian sample.

Author(s): Sharma S, Oliver-Fernandez A, Bakal J, Hollands H, Brown GC, Brown MM. Source: The British Journal of Ophthalmology. 2003 March; 87(3): 259-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12598432

112 Diabetic Retinopathy

•Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy.

Author(s): Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell SE. Source: American Journal of Ophthalmology. 1997 October; 124(4): 433-46.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9323935

•Vascular endothelial growth factor gene regulation and action in diabetic retinopathy.

Author(s): Lu M, Adamis AP.

Source: Ophthalmology Clinics of North America. 2002 March; 15(1): 69-79. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12064083

•Vision after photocoagulation for diabetic retinopathy.

Author(s): Colucciello M.

Source: Postgraduate Medicine. 1998 May; 103(5): 37-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9590985

•Vitrectomy for complications of diabetic retinopathy.

Author(s): Smiddy WE.

Source: International Ophthalmology Clinics. 1998 Spring; 38(2): 155-67. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9604743

•Vitrectomy for traction macular detachment in diabetic retinopathy.

Author(s): Meier P, Wiedemann P.

Source: Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 1997 September; 235(9): 569-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9342607

•Vitrectomy with silicone oil infusion in severe diabetic retinopathy.

Author(s): Castellarin A, Grigorian R, Bhagat N, Del Priore L, Zarbin MA. Source: The British Journal of Ophthalmology. 2003 March; 87(3): 318-21.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12598446

•Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy.

Author(s): Tolentino FI, Cajita VN, Gancayco T, Skates S. Source: Ophthalmology. 1989 October; 96(10): 1495-500.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2587044

Studies 113

•Vitreous levels of insulin-like growth factor-I in patients with proliferative diabetic retinopathy.

Author(s): Inokuchi N, Ikeda T, Imamura Y, Sotozono C, Kinoshita S, Uchihori Y, Nakamura K.

Source: Current Eye Research. 2001 November; 23(5): 368-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11910526

•Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

Author(s): Mitamura Y, Tashimo A, Nakamura Y, Tagawa H, Ohtsuka K, Mizue Y, Nishihira J.

Source: Diabetes Care. 2002 December; 25(12): 2352. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12453985

•Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.

Author(s): Burgos R, Simo R, Audi L, Mateo C, Mesa J, Garcia-Ramirez M, Carrascosa A. Source: Diabetologia. 1997 September; 40(9): 1107-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9300249

•What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control.

Author(s): Am J Ophthalmol. 2001 Sep;132(3):458-61 Source: Diabetes & Metabolism. 2001 June; 27(3): 366-71.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11530091

•What you need to know about diabetic retinopathy.

Author(s): Smith CW, Feldman JP.

Source: R I Med J. 1991 October; 74(10): 459-62. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1957114

•What you should know about diabetic retinopathy.

Author(s): Roach VG.

Source: J Ophthalmic Nurs Technol. 1988 September-October; 7(5): 166-9. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3418723

•When does neural degeneration occur in diabetic retinopathy?

Author(s): Gillies M.

Source: Clinical & Experimental Ophthalmology. 2000 February; 28(1): 1-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11345336

114 Diabetic Retinopathy

•Who should treat diabetic retinopathy?

Author(s): Gregor ZJ.

Source: Eye (London, England). 1988; 2 ( Pt 4): Vii. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3253127

•Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C- peptide and diabetic retinopathy.

Author(s): Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. Source: Diabetes. 1990 November; 39(11): 1445-50.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2121570

•Wolfram (DIDMOAD) syndrome with diabetic retinopathy.

Author(s): Gupta KL, Ghosh AK, Jha V, Gupta A, Sakhuja V.

Source: J Assoc Physicians India. 1994 October; 42(10): 831-2. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7876060

•Worsening of diabetic retinopathy after improvement of glycemic control.

Author(s): Davis MD.

Source: Archives of Ophthalmology. 1998 July; 116(7): 931-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9682709

•Z-2 aldose reductase allele and diabetic retinopathy in India.

Author(s): Kumaramanickavel G, Sripriya S, Ramprasad VL, Upadyay NK, Paul PG, Sharma T.

Source: Ophthalmic Genetics. 2003 March; 24(1): 41-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12660865